bortezomib clonmel 2.5 mg/ml solution for injection (1.4ml vial)
clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - bortezomib - solution for injection - bortezomib 3.5 mg - antineoplastic agents
valtroza powder for solution for injection
spimaco, saudi arabia - bortezomib - powder for solution for injection - 3.5 mg/ml
bortezomib medomie
medomie pharma ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - bortezomib medomie for injection is indicated for the treatment of patients with multiple myeloma.bortezomib medomie for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib medomie in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
bortezomib 2.5 mg/ml solution for injection
ever valinject gmbh - bortezomib - solution for injection - 2.5 milligram(s)/millilitre - bortezomib
brotex 3.5mg powder for solution for inj 3.5 mg
شركة ام اس فارما - ms pharma - bortezomib 3.5 mg - 3.5 mg
veelbore 3.5 mg powder for solution
شركة أدوية الحكمة - hikma pharmaceuticals - bortezomib 3.5 mg - 3.5 mg
velcade injection 3.5 mg/vial
مستودع أدوية أداتكو - adatco drug store - bortezomib 3.5 mg/vial - 3.5 mg/vial
atrenova 3.5 mg
شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - bortezomib 3.5 mg - 3.5 mg
bortezomib 3.5mg powder for solution for injection
baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - bortezomib - powder for solution for injection - bortezomib 3.5 mg - antineoplastic agents
bortezomib clonmel 2.5 mg/ml solution for injection (2.8ml vial)
clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - solution for injection - bortezomib 7 mg - antineoplastic agents